4
Researchers conducted a systematic review of articles that analyzed the effect of medicine remedies used to treat COVID-19 during pregnancy.

Researchers conducted a systematic review of articles that analyzed the effect of medicine remedies used to treat COVID-19 during pregnancy.

RUDN physician Anna Borisova, in collaboration with colleagues from Italy, used effective searches and classified 123 articles on this research topic. A literature review was conducted by searching databases of medical and biological publications: PubMed, the U.S. National Library of Medicine, and Embase (Elsevier), a biomedical database.

Researchers conducted a search between 1st of January and 5th of May, 2020, using the keywords “COVID-19,” “SARS-CoV-2,” “pregnancy,” and “therapy.” The analysis covered only drugs with presumptive effects on COVID-19 whose safe use during pregnancy has been proven by clinical trials in other infectious diseases. Drugs contraindicated in pregnancy or with unknown side effects were not included in this review.

“Pregnant women are a high-risk group for coronavirus complications. The situation is also complicated by the fact that not all medications can be prescribed to pregnant women due to their possible teratogenic effect on the fetus, which poses new challenges for the development of effective and safe medications for this category of COVID-19 patients”, — Anna Borisova, Ph.D. in Medicine, assistant of the Department of Obstetrics and Gynecology, Institute of Medicine, RUDN.

As a result of the study, scientists identified groups of drugs that can be used to treat COVID-19 during pregnancy, as well as indications for their prescription:

  • Antiviral medications: lopinavir, ritonavir, remdesivir.
  • Antimalarial medications: hydroxychloroquine.
  • Anticoagulants medications: Low-molecular-weight heparin (due to increased risk of thromboembolic complications in patients with COVID-19).
  • Steroids medications: betamethasone (to accelerate fetal lung maturation, since SARS-CoV-2 infection during pregnancy, especially in the third trimester, may increase the risk of premature rupture of fetal membranes and premature birth).
  • Antibacterials medications: amoxicillin, azithromycin, ceftriaxone (must be prescribed only if a bacterial infection is suspected).
  • Metformin and statins (can be used as adjuvant therapy, to reduce the required dose of antiviral medication and, therefore, its side effects).
  • Reconvalescent plasma (antibodies contained in the plasma of convalescents reduce the viral load, the severity of the disease, and improve aeration).
  • Immunomodulators medications, such as tocilizumab.
  • Interferon type I.
International scientific cooperation View all
03 Nov 2017
The main goal of the RUDN University and UNISDR Office for Northeast Asia and Global Education and Training Institute for Disaster Risk Reduction at Incheon (UNISDR ONEA-GETI) cooperation is to obtain knowledge about disaster risk reduction and international experience in this area for creating training courses for basic and additional professional education in RUDN
1482
Scientific Conferences View all
03 Nov 2017
RUDN University organized the first 5G Summit R&D Russia on June 19 - 20, 2017
1899
Similar newsletter View all
19 Apr
A huge pizza and a jug of water, why should 5G networks be sliced? The winners of RUDN science competition explain

RUDN summarized the results of the scientific competition "Project Start: work of the science club ". Students of the Faculty of Physics, Mathematics and Natural Sciences have created a project for a managed queuing system using a neural network to redistribute resources between 5G segments. How to increase flexibility, make the network fast and inexpensive and reach more users — tell Gebrial Ibram Esam Zekri ("Fundamental Computer Science and Information Technology", Master's degree, II course) and Ksenia Leontieva ("Applied Mathematics and Computer Science", Master's degree, I course).

19
19 Apr
Lyricists and physicists are now on equal terms: the first humanitarian laboratory opened in RUDN

What is your first association with the word “laboratory”? Flasks and beakers? Microscopes and centrifuges? Yes, many of us would answer the same way.

18
19 Apr
The National Demographic Report 2023 was published with the participation of RUDN. Demographic well-being of Russian regions

The National Demographic Report, 2023 Demographic Well-Being of Russian Regions (hereinafter - the National Demographic Report) was prepared by the scientific team of the Institute of Demographic Studies of the Federal Research Center of the Russian Academy of Sciences, the Vologda Scientific Center of the Russian Academy of Sciences, Peoples' Friendship University of Russia, the Center for Family and Demography of the Academy of Sciences of the Republic of Tatarstan, as well as with the participation of leading scientists from the Republic of Bashkortostan, Stavropol Krai, Volgograd, Ivanovo, Kaliningrad, Nizhny Novgorod, Sverdlovsk Oblasts and Khanty-Mansi Autonomous Okrug–Yugra.

20
Similar newsletter View all